FDA to Study Instagram and Social Media Influencers

The U.S. Food and Drug Administration (FDA)’s Office of Prescription Drug Promotion (OPDP) is interested in how social media affects the public’s perception of drugs. So the agency is running two studies, one that will focus on Instagram influencers while the other will study print direct-to-consumer (DTC) advertising.